Annual Current Liabilities
$3.46 M
+$1.73 M+100.41%
December 1, 2023
Summary
- As of February 26, 2025, NRSN annual total current liabilities is $3.46 million, with the most recent change of +$1.73 million (+100.41%) on December 1, 2023.
- During the last 3 years, NRSN annual current liabilities has risen by +$3.34 million (+2782.50%).
- NRSN annual current liabilities is now at all-time high.
Performance
NRSN Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$3.78 M
+$275.00 K+7.84%
September 1, 2024
Summary
- As of February 26, 2025, NRSN quarterly total current liabilities is $3.78 million, with the most recent change of +$275.00 thousand (+7.84%) on September 1, 2024.
- Over the past year, NRSN quarterly current liabilities has stayed the same.
- NRSN quarterly current liabilities is now -16.58% below its all-time high of $4.54 million, reached on March 1, 2024.
Performance
NRSN Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
NRSN Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +100.4% | 0.0% |
| 3 y3 years | +2782.5% | 0.0% |
| 5 y5 years | +9248.6% | - |
NRSN Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +479.4% | -16.6% | +533.7% |
| 5 y | 5-year | at high | +9248.6% | -16.6% | +3052.5% |
| alltime | all time | at high | +9248.6% | -16.6% | +3052.5% |
NeuroSense Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.78 M(+7.8%) |
| Jun 2024 | - | $3.51 M(-22.6%) |
| Mar 2024 | - | $4.54 M(+31.1%) |
| Dec 2023 | $3.46 M(+100.4%) | $3.46 M(+23.1%) |
| Sep 2023 | - | $2.81 M(-6.5%) |
| Jun 2023 | - | $3.00 M(+67.6%) |
| Mar 2023 | - | $1.79 M(+3.9%) |
| Dec 2022 | $1.73 M | $1.73 M(+112.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $811.00 K(+10.2%) |
| Jun 2022 | - | $736.00 K(-40.1%) |
| Mar 2022 | - | $1.23 M(+105.7%) |
| Dec 2021 | $597.00 K(+397.5%) | - |
| Dec 2021 | - | $597.00 K(+377.6%) |
| Jun 2021 | - | $125.00 K(+4.2%) |
| Dec 2020 | $120.00 K(+224.3%) | $120.00 K |
| Dec 2019 | $37.00 K | - |
FAQ
- What is NeuroSense Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for NeuroSense Therapeutics?
- What is NeuroSense Therapeutics annual current liabilities year-on-year change?
- What is NeuroSense Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for NeuroSense Therapeutics?
- What is NeuroSense Therapeutics quarterly current liabilities year-on-year change?
What is NeuroSense Therapeutics annual total current liabilities?
The current annual current liabilities of NRSN is $3.46 M
What is the all time high annual current liabilities for NeuroSense Therapeutics?
NeuroSense Therapeutics all-time high annual total current liabilities is $3.46 M
What is NeuroSense Therapeutics annual current liabilities year-on-year change?
Over the past year, NRSN annual total current liabilities has changed by +$1.73 M (+100.41%)
What is NeuroSense Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of NRSN is $3.78 M
What is the all time high quarterly current liabilities for NeuroSense Therapeutics?
NeuroSense Therapeutics all-time high quarterly total current liabilities is $4.54 M
What is NeuroSense Therapeutics quarterly current liabilities year-on-year change?
Over the past year, NRSN quarterly total current liabilities has changed by $0.00 (0.00%)